Skip to main content

Lassie: The first-ever painless breath analyser for people with diabetes, a breakthrough in blood glucose monitoring

Objective

Today, dogs are used to detect high and low blood glucose, cancers and are tested for coronavirus.
The new Lassie breath analyser BOYDSense will put the power of a dog’s nose into people’s hands and give them access to gentle health monitoring.
Lassie starts with diabetes as it is an immense burden for 40 million people in Europe. Current glucose monitoring technologies are underused because they are highly invasive, expensive, stigmatising and generate a lot of waste.
Lassie will transform this situation by making measurements painless, simple, discreet and cost-effective without any consumables. By analysing Volatile Organic Compounds (VOCs) in the breath, Lassie will calculate blood glucose value within current accuracy standard. As a result, Lassie users will test earlier in the disease and more frequently, leading to better diabetes management and significant cost savings. EIC Accelerator will put BOYDSense on track to become a global leader in non-invasive diabetes monitoring.

Coordinator

BOYDSENSE
Net EU contribution
€ 2 500 000,00
Address
4 Rue Brindejonc Des Moulinais
31500 Toulouse
France

See on map

Region
Occitanie Midi-Pyrénées Haute-Garonne
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 8 346 250,00